Pharos iBio Co., Ltd. (KOSDAQ: 388870)
South Korea
· Delayed Price · Currency is KRW
7,440.00
-360.00 (-4.62%)
Dec 20, 2024, 9:00 AM KST
Pharos iBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 4,629 | 15,588 | 3,812 | 18,812 | 9,807 | 3,602 |
Short-Term Investments | 12,589 | 9,899 | 11,267 | 5,000 | 5,000 | 900 |
Cash & Short-Term Investments | 17,218 | 25,487 | 15,079 | 23,812 | 14,807 | 4,502 |
Cash Growth | -37.93% | 69.02% | -36.67% | 60.82% | 228.90% | - |
Accounts Receivable | -0 | 0 | 0 | -0 | 0 | 17.41 |
Other Receivables | 157.26 | 176.56 | 195.54 | 48.02 | 55.64 | 40.04 |
Receivables | 157.26 | 176.56 | 195.54 | 48.01 | 55.64 | 57.45 |
Prepaid Expenses | 77.81 | 160.37 | 167.89 | 234.56 | 111.19 | 385.66 |
Other Current Assets | 359.71 | 346.75 | 272.46 | 327.31 | 257.47 | 13.11 |
Total Current Assets | 17,813 | 26,170 | 15,715 | 24,422 | 15,232 | 4,958 |
Property, Plant & Equipment | 2,971 | 3,218 | 2,541 | 2,700 | 1,398 | 1,199 |
Long-Term Investments | -0 | 0.13 | 0 | -0 | 0 | 200.94 |
Other Intangible Assets | 96.06 | 148.95 | 203.04 | 264.56 | 64.9 | 95.83 |
Other Long-Term Assets | 136.66 | 153.17 | 262.56 | 99.59 | 6.92 | 0.77 |
Total Assets | 21,017 | 29,690 | 18,721 | 27,486 | 16,702 | 6,455 |
Accrued Expenses | 129.3 | 86.3 | 131.83 | 51.55 | 23.31 | 13.53 |
Current Portion of Long-Term Debt | - | - | 106.25 | 125 | 325 | 125 |
Current Portion of Leases | 113.78 | 177.25 | 154.31 | 151.2 | 8.02 | - |
Other Current Liabilities | 364.37 | 949.8 | 558.56 | 42,373 | 16,885 | 7,575 |
Total Current Liabilities | 607.45 | 1,213 | 950.95 | 42,700 | 17,241 | 7,713 |
Long-Term Debt | - | - | - | 106.25 | 231.25 | 556.25 |
Long-Term Leases | 48.78 | 127.7 | 105.12 | 209.17 | 23.87 | - |
Other Long-Term Liabilities | -0 | -0 | 0 | 6.87 | 22.93 | 162.33 |
Total Liabilities | 656.23 | 1,341 | 1,056 | 43,282 | 17,567 | 8,491 |
Common Stock | 6,459 | 6,459 | 5,738 | 2,902 | 967.28 | 925 |
Additional Paid-In Capital | 101,927 | 101,927 | 83,576 | 1,307 | 3,260 | 1,514 |
Retained Earnings | -90,158 | -81,771 | -72,913 | -55,997 | -24,454 | -10,986 |
Comprehensive Income & Other | 2,132 | 1,734 | 1,264 | 604.87 | 180.43 | 1,767 |
Total Common Equity | 20,360 | 28,349 | 17,665 | -51,184 | -20,046 | -6,780 |
Shareholders' Equity | 20,360 | 28,349 | 17,665 | -15,796 | -865.04 | -2,037 |
Total Liabilities & Equity | 21,017 | 29,690 | 18,721 | 27,486 | 16,702 | 6,455 |
Total Debt | 162.55 | 304.95 | 365.68 | 591.61 | 588.14 | 681.25 |
Net Cash (Debt) | 17,056 | 25,182 | 14,714 | 23,221 | 14,219 | 3,821 |
Net Cash Growth | -37.70% | 71.15% | -36.64% | 63.31% | 272.15% | - |
Net Cash Per Share | 1319.98 | 2080.94 | 1656.70 | 4001.05 | 2514.86 | 688.31 |
Filing Date Shares Outstanding | 12.92 | 12.92 | 11.48 | 5.8 | 0.19 | 5.55 |
Total Common Shares Outstanding | 12.92 | 12.92 | 11.48 | 5.8 | 0.19 | 5.55 |
Working Capital | 17,206 | 24,957 | 14,764 | -18,278 | -2,010 | -2,755 |
Book Value Per Share | 1576.00 | 2194.39 | 1539.19 | -8819.20 | -103622.56 | -1221.44 |
Tangible Book Value | 20,264 | 28,200 | 17,462 | -51,448 | -20,111 | -6,876 |
Tangible Book Value Per Share | 1568.57 | 2182.86 | 1521.50 | -8864.79 | -103958.01 | -1238.70 |
Land | 367 | 367 | 367 | 367 | 367 | 367 |
Buildings | 782.08 | 782.08 | 782.08 | 782.08 | 782.08 | 656.8 |
Machinery | 2,336 | 1,980 | 1,445 | 1,239 | 389.73 | 241.3 |
Source: S&P Capital IQ. Standard template. Financial Sources.